These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 31756235)

  • 1. Interleukin 21 (IL-21) regulates chronic allograft vasculopathy (CAV) in murine heart allograft rejection.
    Khattar M; Baum CE; Schroder P; Breidenbach JD; Haller ST; Chen W; Stepkowski S
    PLoS One; 2019; 14(11):e0225624. PubMed ID: 31756235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8+ lymphocytes augment chronic rejection in a MHC class II mismatched model.
    Fischbein MP; Yun J; Laks H; Irie Y; Fishbein MC; Espejo M; Bonavida B; Ardehali A
    Transplantation; 2001 Apr; 71(8):1146-53. PubMed ID: 11374417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-16 deficiency suppresses the development of chronic rejection in murine cardiac transplantation model.
    Kimura N; Itoh S; Nakae S; Axtell RC; Velotta JB; Bos EJ; Merk DR; Gong Y; Okamura H; Nagamine CM; Adachi H; Kornfeld H; Robbins RC; Fischbein MP
    J Heart Lung Transplant; 2011 Dec; 30(12):1409-17. PubMed ID: 22055099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monokine induced by interferon-gamma (MIG/CXCL9) is derived from both donor and recipient sources during rejection of class II major histocompatibility complex disparate skin allografts.
    Auerbach MB; Shimoda N; Amano H; Rosenblum JM; Kish DD; Farber JM; Fairchild RL
    Am J Pathol; 2009 Jun; 174(6):2172-81. PubMed ID: 19389928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cells play a critical role in cardiac allograft vasculopathy in an interleukin-6--dependent manner.
    Zhang ZX; Huang X; Jiang J; Lian D; Min WP; Liu W; Haig A; Jevnikar AM
    Transplantation; 2014 Nov; 98(10):1029-39. PubMed ID: 25286056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of myeloid related protein-8/14 exacerbates cardiac allograft rejection.
    Shimizu K; Libby P; Rocha VZ; Folco EJ; Shubiki R; Grabie N; Jang S; Lichtman AH; Shimizu A; Hogg N; Simon DI; Mitchell RN; Croce K
    Circulation; 2011 Dec; 124(25):2920-32. PubMed ID: 22144572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy.
    Yang J; Popoola J; Khandwala S; Vadivel N; Vanguri V; Yuan X; Dada S; Guleria I; Tian C; Ansari MJ; Shin T; Yagita H; Azuma M; Sayegh MH; Chandraker A
    Circulation; 2008 Feb; 117(5):660-9. PubMed ID: 18212277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy.
    Yuan X; Paez-Cortez J; Schmitt-Knosalla I; D'Addio F; Mfarrej B; Donnarumma M; Habicht A; Clarkson MR; Iacomini J; Glimcher LH; Sayegh MH; Ansari MJ
    J Exp Med; 2008 Dec; 205(13):3133-44. PubMed ID: 19047438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of CD8+ lymphocytes in chronic rejection of transplanted hearts.
    Fischbein MP; Yun J; Laks H; Irie Y; Fishbein MC; Bonavida B; Ardehali A
    J Thorac Cardiovasc Surg; 2002 Apr; 123(4):803-9. PubMed ID: 11986610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of allograft responses induced by interleukin-6, which selectively modulates interferon-gamma but not interleukin-2 production.
    Tomura M; Nakatani I; Murachi M; Tai XG; Toyo-oka K; Fujiwara H
    Transplantation; 1997 Sep; 64(5):757-63. PubMed ID: 9311716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-gamma is necessary for initiating the acute rejection of major histocompatibility complex class II-disparate skin allografts.
    Ring GH; Saleem S; Dai Z; Hassan AT; Konieczny BT; Baddoura FK; Lakkis FG
    Transplantation; 1999 May; 67(10):1362-5. PubMed ID: 10360591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-22 deficiency accelerates the rejection of full major histocompatibility complex-disparate heart allografts.
    Kapessidou P; Poulin L; Dumoutier L; Goldman M; Renauld JC; Braun MY
    Transplant Proc; 2008 Jun; 40(5):1593-7. PubMed ID: 18589157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic rejection in H-2 matched cardiac allografts: early emergence of vasculopathy, alloantibody, and accumulation of IFN-gamma and IL-10 mRNA.
    Zhang QW; Tomita Y; Matsuzaki G; Uchida T; Yoshikawa M; Nakashima Y; Sueishi K; Nomoto K; Yasui H
    Transpl Int; 2001 Jun; 14(3):143-52. PubMed ID: 11499903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockout of microRNA-155 ameliorates the Th1/Th17 immune response and tissue injury in chronic rejection.
    Zhang A; Wang K; Zhou C; Gan Z; Ma D; Ye P; Sun Y; Wu J; Huang X; Ren L; Deng P; Wu C; Yue Z; Ding X; Chen J; Xia J
    J Heart Lung Transplant; 2017 Feb; 36(2):175-184. PubMed ID: 27296836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft.
    Buonocore S; Flamand V; Goldman M; Braun MY
    Transplantation; 2003 Feb; 75(3):407-13. PubMed ID: 12589166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin Synergizes With Mesenchymal Stromal Cells Attenuates Chronic Allograft Vasculopathy.
    Qin YF; Kong DJ; Qin H; Zhu YL; Li GM; Sun CL; Zhao YM; Wang HD; Hao JP; Wang H
    Front Immunol; 2021; 12():672849. PubMed ID: 33995416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical influence of natural regulatory CD25+ T cells on the fate of allografts in the absence of immunosuppression.
    Benghiat FS; Graca L; Braun MY; Detienne S; Moore F; Buonocore S; Flamand V; Waldmann H; Goldman M; Le Moine A
    Transplantation; 2005 Mar; 79(6):648-54. PubMed ID: 15785370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germinal Center Alloantibody Responses Mediate Progression of Chronic Allograft Injury.
    Chhabra M; Alsughayyir J; Qureshi MS; Mallik M; Ali JM; Gamper I; Moseley EL; Peacock S; Kosmoliaptsis V; Goddard MJ; Linterman MA; Motallebzadeh R; Pettigrew GJ
    Front Immunol; 2018; 9():3038. PubMed ID: 30728823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-5 mediates eosinophilic rejection of MHC class II-disparate skin allografts in mice.
    Le Moine A; Surquin M; Demoor FX; Noël JC; Nahori MA; Pretolani M; Flamand V; Braun MY; Goldman M; Abramowicz D
    J Immunol; 1999 Oct; 163(7):3778-84. PubMed ID: 10490975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmunity to vimentin potentiates graft vasculopathy in murine cardiac allografts.
    Mahesh B; Leong HS; Nair KS; McCormack A; Sarathchandra P; Rose ML
    Transplantation; 2010 Jul; 90(1):4-13. PubMed ID: 20463646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.